Correct answer: adenosine deaminase deficiency
The first clinical gene therapy was performed for adenosine deaminase (ADA) deficiency, a form of severe combined immunodeficiency. It was chosen because the disease is caused by a known single-gene defect and restoring the missing enzyme can directly improve immune function.